Acquisition of medicines from therapeutic group c - cardiovascular system for the health establishments of the canton of Loja belonging to zonal coordination 7 health

This tender, identified by process code SIE-CZ7S-2025-004-442675, concerns the acquisition of cardiovascular system medications, specifically from Therapeutic Group C, for health establishments within the Loja Canton. The procuring entity is COORDINACION ZONAL 7-SALUD (Zonal Coordination 7 Health). The procurement method is Electronic Reverse Auction, a modality designed to foster competitive bidding among suppliers. The primary objective is to ensure a consistent and adequate supply of essential cardiovascular drugs to healthcare facilities under the purview of Zonal Coordination 7 Health. A key item specified in the tender documents is Atorvastatin, presented in solid oral form, with a dosage of 20 mg, packaged in blister/strip boxes. The required quantity for this specific item is listed as 1 Unit, with an estimated value of USD 28,363.10. This acquisition is critical for maintaining the operational capacity of local health services and ensuring patient access to necessary treatments for cardiovascular conditions. The tender invites eligible suppliers to participate in the electronic reverse auction to provide these vital pharmaceutical products, adhering to the specified quality standards and delivery timelines.

This is a supplies contract in the governance and public administration sector. Located in Ecuador, Latin America, this opportunity is open to firms and consortiums, with an estimated budget of USD 28,363.

Published through SERCOP Ecuador, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the governance and public administration sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.